Desiree Eugenie Simon

Desiree Simon practices at Nova Southeastern University, Inc in Davie, Florida.

Desiree Simon's NPI, 1356014591, was assigned on July 25, 2021. Desiree Simon holds Florida license 11015172.

Desiree Simon's primary practice is Nova Southeastern University, Inc, at 3200 S University Dr, Davie, FL 33328 in Broward County. The practice phone is (954) 262-4100.

Desiree Simon's primary practice is Nova Southeastern University, Inc in Davie, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Desiree Simon to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Desiree Simon practices, 2 sites in all. Vendor and product names are available with a free account.

Primary care is Desiree Simon's primary specialty in the NPI Registry, under taxonomy code 363LP2300X. Desiree Simon is licensed in Florida.

Dmand AI lists acute sinusitis, alzheimer's disease, chronic obstructive pulmonary disease (COPD), enlarged prostate, epilepsy, muscle pain, fibromyalgia, and limb pain, non-alzheimer's dementia (chronic) and underactive thyroid among the conditions Desiree Simon treats.

CMS data shows 72 Medicare services from Desiree Simon across 3 procedure codes in 2024, for 36 Medicare patients. Medicare paid $2,096 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Desiree Simon in 2024. The largest group is 85 and over, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Desiree Simon's median patient age at 70, with 58% women.

In 2024, Desiree Simon wrote 846 Medicare Part D claims for 116 patients. 75% of them were for generic drugs. CMS names the drug for 466 of them, across 19 drugs with 11 or more claims each, at $84,004 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 72 out of 100 for Desiree Simon for performance year 2024, reported as part of a group. Desiree Simon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Desiree Simon from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $43.